Notice: 函数 WP_Styles::add 的调用方法不正确。 The style with the handle "storefront-woocommerce-style" was enqueued with dependencies that are not registered: storefront-style. 请查阅调试 WordPress来获取更多信息。 (这个消息是在 6.9.1 版本添加的。) in /wordpress/wp-includes/functions.php on line 6260

KB-1376

PRA023-hIgG1

Home » Antibodies » PRA023-hIgG1

Background of PRA023-hIgG1

TL1A, also known as TNFSF15, is a member of the tumor necrosis factor (TNF) family. It is expressed by monocytes, macrophages, dendritic cells (DCs), synovial fibroblasts, and endothelial cells in response to stimulation by cytokines, immune complexes, and microorganisms. PRA023 is an IgG1 humanized monoclonal antibody designed to block tumor necrosis factor-like ligand 1A (TL1A). It binds both soluble and membrane-associated human TL1A with high affinity and specificity. PRA023 holds significant potential for improving outcomes in patients with moderate-to-severe inflammatory bowel disease (IBD) who are predisposed to increased TL1A expression.

Specifications

Catalog Number:
KB-1376
Antibody Name:
PRA023-hIgG1
Isotype:
Human IgG1,kappa
FC Muations:
Target:
TL1A
Species Reactivity:
Human
Host Cell Line:
EXPI CHO
Purification Method:
Affinity purified
Concentration:
>2 mg/mL
Formulation:
50 mM sodium citrate,150mM NaCl,pH5.5
Purity:
>95% by SDS-PAGE and SEC-HPLC
Validation:
ELISA
Endotoxin Level:
<0.2 EU/mg as determined by the LAL method
Sterility:
0.2μm filtered
Storage:
It is recommended that the protein should be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Stability:
Stable for twelve months from date of receipt when stored at -20°C to -80°C; Stored at 2-8°C for one month without detectable loss of activity.

Characterization

Application

References

  1. Migone, T.S. et al. TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity 16, 479–492 (2002).
  2. Shih, D.Q. et al. Microbial induction of inflammatory bowel disease associated gene TL1A (TNFSF15) in antigen presenting cells. Eur. J. Immunol. 39, 1–12 (2009).